A carregar...

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study

BACKGROUND: The dose and time point for switching from clopidogrel to ticagrelor remain controversial, especially for Chinese acute coronary syndrome (ACS) patients with complicated coronary artery disease (CAD). Hence, the purpose of this study was to further explore the optimal dose and time point...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chin Med J (Engl)
Main Authors: Yao, Ying, Wang, Ping, Wang, Xiao-Zeng, Zhao, Xin, Zhao, Wei, Zhou, Tie-Nan, Zhang, Lei
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6819042/
https://ncbi.nlm.nih.gov/pubmed/31567375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000000444
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!